GEN-PROBE ACCUPROBE GROUP B STREPTOCOCCUS CULTURE IDENTIFICATION TEST 2820
Sep 1998
293d
Chugai Pharmaceuticals Co., Ltd. has submitted 1 FDA 510(k) premarket notifications since 1998, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Dna-probe, Reagents, Streptococcal . Use the specialty filter in the sidebar to narrow results.